Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  fluorine F 18 sodium fluoride
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-13 of 13 for your search:
Start Over
F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
Phase: Phase III
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: AMI-2008-01, NCT00882609
18F-NaF PET Imaging for Bone Scintigraphy
Phase: Phase III
Type: Diagnostic
Status: Active
Age: 18 or 19 and over
Sponsor: Other
Protocol IDs: MITNEC-A1, NCT01930812
A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 30 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: DEK-DKK1-P101, DKN-01, LY2812176, NCT01711671
Cabozantinib for Advanced Urothelial Cancer
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120205, 12-C-0205, NCT01688999
Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer
Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 13365, NCI-2013-01924, NCT01967862
A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MDV3100-18, NCT02384382
18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 941220, NCT00414934
Combined F18 and F18 FDG PET/CT for Evaluation of Malignancy
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: VAR0024, 98043, SU-07232008-1266, NCT00725387
Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H-3-2010-019, NCT01224873
PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NYU S12-03902, NCT02042053
Functional Imaging in Multiple Myeloma -PET/CT and Diffusion Weighted Imaging in Multiple Myeloma
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: S-20120209, 13/24748, NCT02187731
NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: PROS0063, NCI-2015-00553, ep 32653, 96754, P30CA124435, NCT02429804
Start Over